Research News and Research

RSS

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star today announced that it has entered into a collaboration and license agreement with AbbVie to research and develop bispecific antibodies in immuno-oncology. Financial terms were not disclosed.

11 Jan 2016

Finding cost-effective ways of lowering blood pressure among adults living in rural Southeast Asia

Researchers from the Duke Global Health Institute and their international collaborators are launching a study to find cost-effective ways of lowering blood pressure in adults living in rural in South Asia.

11 Jan 2016

UA researchers find genetic mutations associated with respiratory disease

Asthma affects more than 278 million people worldwide and can lead to serious consequences later in life. While current approved therapies address symptoms, they do not halt disease progression.

11 Jan 2016

1 in 10 veterans and civilian patients experiences new ICU-related PTSD up to one year after discharge

One in ten patients is at risk of having new post-traumatic stress disorder (PTSD) related to their ICU experience up to a year post-discharge. This was the finding from a multicenter, prospective cohort research study of veterans and civilians.

11 Jan 2016

Intake of Bimuno in early life benefits brain development

Clasado Biosciences Limited, the producers and suppliers of Bimuno® (B-GOS), a unique patented trans-galactooligosaccharide complex, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study, demonstrating for the first time a major role of B-GOS in modulating brain development at the molecular level in early life stages.

11 Jan 2016

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

Today, Janssen-Cilag International NV announced that for the first time, European clinicians in six countries will meet to view and discuss broadcasts of the latest scientific research presented at the 2016 Genitourinary Cancers Symposium, co-sponsored by ASCO®.

11 Jan 2016

Global supply of oral cholera vaccines expected to double with new producer

The global supply of oral cholera vaccines is set to double after WHO approved a third producer, helping to address global shortages and expand access in more countries.

11 Jan 2016

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

New research by UC San Francisco stem cell biologists has revealed that a DNA-binding protein called Foxd3 acts like a genetic traffic signal, holding that ball of undifferentiated cells in a state of readiness for its great transformation in the third week of development.

11 Jan 2016

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

Biochemists at The University of Texas at Arlington are mapping the catalytic processes of sulfur-oxidizing enzymes to improve understanding of the chemical imbalances found in patients with autism, Alzheimer's disease and Down syndrome.

11 Jan 2016

UVA's brain discovery hailed as one of 2015's biggest scientific breakthroughs

A shocking discovery about the human brain made at the University of Virginia School of Medicine is being hailed as one of 2015's biggest scientific breakthroughs by numerous year-end lists, including those compiled by Scientific American, Science, The Huffington Post and the National Institutes of Health.

11 Jan 2016

U-M research could lead to new ways of fighting X-linked diseases in girls and women

Nearly every girl and woman on Earth carries two X chromosomes in nearly every one of her cells -- but one of them does (mostly) nothing. That's because it's been silenced, keeping most of its DNA locked up and unread like a book in a cage.

11 Jan 2016

CTCA at Western announces launch of Phase II NivoPlus clinical trial

Cancer Treatment Centers of America at Western Regional Medical Center in Goodyear, Arizona, has announced the launch of Phase II of the NivoPlus clinical trial, which combines the immunotherapeutic agent nivolumab with chemotherapy drugs irinotecan and capecitabine.

11 Jan 2016

New classification of coronary congenital diseases helps surgeons identify secondary defects

A new classification of coronary congenital diseases is set to help surgeons identify secondary defects in the operating theatre. The scheme is outlined in a novel European Society of Cardiology position paper published today in Cardiovascular Research.1 Clinical cardiologists will also know what to look for on cardiovascular images.

11 Jan 2016

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.

11 Jan 2016

Auranofin drug could improve prognosis for ovarian cancer patients exhibiting BRCA1 deficiency

An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.

11 Jan 2016

Virginia Tech scientists find potential way to influence memory formation in the immune system

Scientists at the Virginia Tech Carilion Research Institute have found a potential way to influence long-term memory formation in the immune system. The researchers published their results today in Nature Communications.

11 Jan 2016

Chromoendoscopy superior to other surveillance methods in detecting dysplasia in IBD patients

Chromoendoscopy is superior to random biopsy or white-light colonoscopy in detecting dysplasia in patients with inflammatory bowel diseases (IBD), according to a long-term surveillance study led by James F. Marion, MD, Professor of Medicine at Icahn School of Medicine at Mount Sinai, and Director of Education and Outreach at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at The Mount Sinai Hospital, published online in the journal Clinical Gastroenterology and Hepatology.

11 Jan 2016

Researchers reveal specific enzyme responsible for sensing energy source that fuels growth of cancer cells

An international research team formed by a University of Cincinnati cancer researcher has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP, an energy source that fuels the uncontrolled growth of cancer cells. The research underscores the enzyme's potential to become a therapeutic target for future cancer drugs.

11 Jan 2016

NUS-led study discovers potential therapeutic approach against colorectal cancer

A study led by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has demonstrated the efficiency of a small molecule drug, PRIMA-1met, in inhibiting the growth of colorectal cancer cells. Colorectal cancer is the cancer of the large intestine (colon and rectum) and is the most common cancer in Singapore.

11 Jan 2016

Head-down yoga positions fatal for glaucoma patients

Glaucoma patients may experience increased eye pressure as the result of performing several different head-down positions while practicing yoga, according to a new study published by researchers at New York Eye and Ear Infirmary of Mount Sinai in the journal PLOS ONE.

11 Jan 2016

Research News and Research

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

Finding cost-effective ways of lowering blood pressure among adults living in rural Southeast Asia

UA researchers find genetic mutations associated with respiratory disease

1 in 10 veterans and civilian patients experiences new ICU-related PTSD up to one year after discharge

Intake of Bimuno in early life benefits brain development

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

Global supply of oral cholera vaccines expected to double with new producer

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

UVA's brain discovery hailed as one of 2015's biggest scientific breakthroughs

U-M research could lead to new ways of fighting X-linked diseases in girls and women

CTCA at Western announces launch of Phase II NivoPlus clinical trial

New classification of coronary congenital diseases helps surgeons identify secondary defects

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

Auranofin drug could improve prognosis for ovarian cancer patients exhibiting BRCA1 deficiency

Virginia Tech scientists find potential way to influence memory formation in the immune system

Chromoendoscopy superior to other surveillance methods in detecting dysplasia in IBD patients

Researchers reveal specific enzyme responsible for sensing energy source that fuels growth of cancer cells

NUS-led study discovers potential therapeutic approach against colorectal cancer

Head-down yoga positions fatal for glaucoma patients

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation